Effect of topical dexamethasone versus rimexolone on middle ear inflammation in experimental otitis media with effusion

Acta Oto-Laryngologica

Volumn 126, Issue 9, 2006, Pages 910-915

  Florea, Andrew ^a,b   Zwart, Jon E ^a,b   Lee, Choong Won ^a,b   Depew, Aron ^a,b   Park, Seong Kook ^a,b   Inman, Jared ^a,b   Wareham, Rachelle ^a,b   Johnson, Kaalan ^a,b   John, Earnest ^a,b   Wall, G Michael ^c   Jung, Timothy K ^a,b  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Jerry L Pettis Veterans Medical Center   (United States)

^c Alcon Research Ltd   (United States)

Author keywords

Chinchilla; Corticosteroids; Dexamethasone; Lipopolysaccharide induced otitis media; Middle ear effusion; Rimexolone

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; PREGNANE DERIVATIVE; RIMEXOLONE;

ANIMAL; ARTICLE; CHINCHILLA; DISEASE MODEL; DRUG EFFECT; FEMALE; MALE; MICROSCOPY; MUCOSA; PATHOLOGY; PERIOSTEUM; RANDOMIZATION; SECRETORY OTITIS MEDIA; TEMPORAL BONE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; CHINCHILLA; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FEMALE; GLUCOCORTICOIDS; MALE; MICROSCOPY; MUCOUS MEMBRANE; OTITIS MEDIA WITH EFFUSION; PERIOSTEUM; PREGNADIENES; RANDOM ALLOCATION; TEMPORAL BONE;

EID: 37349010217     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480600606699     Document Type: Article

References (24)

1. Kenna MA, Rosane BA, Bluestone CD. Medical management of chronic suppurative otitis media without cholesteatoma in children - update. Am J Otol 1993;14:469.
2. Fliss DM, Dagan R, Houri Z, Leiberman A. Medical management of chronic suppurative otitis media without cholesteatoma in children. J Pediatr 1990;116:991-6.
3. Berman S. Otitis media in children. N Engl J Med 1995;332:1560-5.
4. Jung TT. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in the pathogenesis of otitis media. Laryngoscope 1998;98:980-93.
5. Jung TT, Choi K, Park YS, Schlund D. Effect of prostaglandin, leukotriene, and arachidonic acid on experimental otitis media with effusion in chinchillas. Ann Otol Rhinol Laryngol 1990;99:28-32.
6. Decadron. Available from: http://www.healthsqare.com/nrwrx/dec1118.htm
7. Baggett HC, Prazma J, Rose AS, Lane AP, Pillsbury HC III. The role of glucocorticoids in endotoxin-mediated otitis media with effusion. Arch Otolaryngol Head Neck Surg 1997;123:41-6.
8. Herman P, Tan CT, Van Den Abbeele T, Escoubet B, Friedlander G, Huy PT. Glucocorticosteroids increase sodium transport in middle ear epithelium. Am J Physiol 1997;272:184-90.
9. Paparella MM, Schachern P. New developments in treating otitis media. Ann Otol Rhinol Laryngol Suppl 1997;163:7-10.
10. Yang JFC. Rimexolone: a new ophthalmic corticosteroid with low intraocular pressure-raising potential. Drugs of Today 1997;33:123-9.
11. Brogden RN. Rimexolone: a review of its pharmacological properties and clinical potential in the management of ocular inflammation. Biodrugs 1997;8:66-79.
12. Fliss DM, Dagan R, Meidan N, Leiberman A. Aerobic bacteriology of chronic suppurative otitis media without cholesteatoma in children. Ann Otol Rhinol Laryngol 1992;101:866-9.
13. Bluestone CD, Stool SE, Kenna MA. Pediatric otolaryngology, 3rd edn. Philadelphia: WB Saunders; 1996.
14. Johnson MD, Fitzgerald JE, Leonard G, Burleson JA, Kreutzer DL. Cytokines in experimental otitis media with effusion. Laryngoscope 1994;104:191-6.
15. Jung HH, Kim MW, Lee JH, Kim YT, Kim NH, Chang BA, et al. Expression of vascular endothelial growth factor in otitis media. Acta Otolaryngol 1999;119:801-8.
16. Skotnicka B, Hassmann E. Cytokines in children with otitis media with effusion. Eur Arch Otorhinolaryngol 2000;257:323-6.
17. John EO, Russell PT, Nam B, Jinn TH, Jung TT. Concentration of nitric oxide metabolites in middle ear effusion. Int J Pediatr Otorhinolaryngol 2001;60:55-8.
18. Chonmaitree T, Patel JA, Lett-Brown MA, Uchinda TR, Garofalo MJ, Owen VM, et al. Virus and bacteria enhance histamine production in middle ear fluids of children with acute otitis media. J Infect Dis 1994;169:1265-70.
19. Rhee CK, Jung TT, Miller S, Weeks D. Experimental otitis media with effusion induced by platelet activating factor. Ann Otol Rhinol Laryngol 1993;2:600-5.
20. Catanzaro A, Ryan A, Batcher S, Wasserman SI. The response to human rIL-1, rIL-2, and rTNF in the middle ear of guinea pigs. Laryngoscope 1991;101:271-5.
21. Schousboe LP, Ovesen T, Pedersen CB. Middle ear epithelium has inflammatory capacity. Acta Otolaryngol Suppl 2000;543:89-91.
22. Roland PS, Kreisler LS, Reese B, Anon JB, Lanier B, Conroy PJ, et al. Topical ciprofloxacin/dexamethasone otic suspension is superior to oflaxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 2004;113:40-6.
23. Dohar JE, Wall M, Roland PS, Dupre SJ, Potts SL, Conroy PJ, et al. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in AOMT. Poster R507. Am Acad Otolaryngol Head Neck Surg, Los Angeles, September 24, 2005.
24. Juhn SK, Jung TT. Inflammatory changes reflected in middle ear effusion in otitis media. Auris Nasus Larynx 1985;(12 Suppl 1):S63-6.